Fusarium solani infection after antimicrobial treatment of a severe bacterial peritonitis: a case report and review of the literature

Authors

  • Jari Intra Department of Laboratory Medicine, Azienda Socio Sanitaria Territoriale di Monza ASST-Monza, Desio Hospital, Desio, Italy
  • Cecilia Sarto Department of Laboratory Medicine, Azienda Socio Sanitaria Territoriale di Monza ASST-Monza, Desio Hospital, Desio, Italy
  • Sara Auricchio Department of Nephrology and Dialysis, Azienda Socio Sanitaria Territoriale di Monza ASST-Monza, Desio Hospital, Desio, Italy
  • Marco Pozzi Department of Nephrology and Dialysis, Azienda Socio Sanitaria Territoriale di Monza ASST-Monza, Desio Hospital, Desio, Italy
  • Federico Pieruzzi Department of Nephrology and Dialysis, Azienda Socio Sanitaria Territoriale di Monza ASST-Monza, Desio Hospital, Desio, Italy
  • Paolo Brambilla Department of Laboratory Medicine, Azienda Socio Sanitaria Territoriale di Monza ASST-Monza, Desio Hospital, Desio, Italy

DOI:

https://doi.org/10.18203/2320-6012.ijrms20195556

Keywords:

Antifungal treatment, Catheter removal, Fusarium, Matrix-assisted laser desorption ionization-time of flight mass spectrometry, Peritonitis

Abstract

Fungal peritonitis is a rare but serious complication of peritoneal dialysis. This infection has been reported to be mostly caused by Candida species, and less frequently by a variety of other yeasts and moulds, such as Aspergillus, Penicillium, and  Fusarium spp. are commonly isolated from soil, plants and environmental surfaces, and rarely from non-immunosuppressed subjects. In this report, author describe a case of infection caused by Fusarium solani in a 59-year-old man undergoing continuous ambulatory peritoneal dialysis. The fungus was recovered from cultures of peritoneal dialysate and the pathogen identification was carried out by mass spectrometry. The patient's outcome was favorable without complications after liposomal amphotericin B treatment along with peritoneal dialysis catheter removal.

References

Cho Y, Johnson DW. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kid Dis. 2014;64(2):278-89.

Barretti P, Moraes TM, Camargo CH, Caramori JC, Mondelli AL, Montelli AC, et al. Peritoneal dialysis-related peritonitis due to Staphylococcus aureus: a single-center experience over 15 years. PloS One. 2012;7(2):31780.

García-Agudo R, García-Martos P. Clinical and microbiological aspects of fungal peritonitis in peritoneal dialysis. Nefrologia. 2009;29(6):506-17.

Matuszkiewicz-Rowinska J. Update on fungal peritonitis and its treatment. Perit Dial Int 2009;29:S161-5.

Chang TI, Kim HW, Park JT, Lee DH, Lee JH, Yoo TH, et al. Early catheter removal improves patient survival in peritoneal dialysis patients with fungal peritonitis: results of ninety-four episodes of fungal peritonitis at a single center. Periton Dialys Intern. 2011;31(1):60-6.

Auricchio S, Giovenzana ME, Pozzi M, Galassi A, Santorelli G, Dozio B, et al. Fungal peritonitis in peritoneal dialysis: a 34-year single centre evaluation. Clini kid J. 2018;11(6):874-80.

Gaur S, Rajgopal A, Ashbee R. A successfully treated case of peritonitis due to Fusarium dimerum. J Infect. 2010;61(1):86-8.

Huang JW, Chu TS, Wu MS, Peng YS, Hsieh BS. Visible Penicillium spp. colonization plaques on a Tenckhoff catheter without resultant peritonitis in a peritoneal dialysis patient. Nephrol Dialys Transplant. 2000;15(11):1872-3.

Roberts DM, Kauter G, Ray JE, Gillin AG. Intraperitoneal voriconazole in a patient with Aspergillus peritoneal dialysis peritonitis. Periton Dialys Intern. 2013;33(1):92-3.

Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect. 200;10:67-75.

Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Periton Dialys Intern. 2016;36(5):481-508.

Clinical and Laboratory Standards Institute. Performance Standards for Antifungal Susceptibility Testing of Filamentous Fungi (M61), 2017. Available at: https:// clsi.org /media/ 1896/ m61ed1_sample.pdf. Accessed 1 September 2019.

Garbino J, Uckay I, Rohner P, Lew D, Delden CV. Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature. Transpl Intern. 2005;18(5):613-8.

Unal A, Kocyigit I, Sipahioglu MH, Tokgoz B, Oymak O, Utas C. Fungal peritonitis in peritoneal dialysis: an analysis of 21 cases. Int Urol Nephrol. 2011;43(1):211-3.

Prasad N, Gupta A. Fungal peritonitis in peritoneal dialysis patients. Perit Dial Int. 2005;25(3):207-22

Lye WC. Nystatin prophylaxis for fungal peritonitis: to be or not to be? Perit Dial Int. 2007;27(5):511-3

Restrepo C, Chacon J, Manjarres G. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial. Periton Dialy Intern. 2010;30(6):619-25.

Prabhu MV, Subhramanyam SV, Gandhe S, Antony SK, Nayak KS. Prophylaxis against fungal peritonitis in CAPD-a single center experience with low-dose fluconazole. Renal failu. 2010;32(7):802-5.

Patel GP, Crank CW, Leikin JB. An evaluation of hepatotoxicity and nephrotoxicity of liposomal amphotericin B (L-AMB). J Med Toxicol 2011;7(1):12-5.

Szeto CC, Li PK, Johnson DW, Bernardini J, Dong J, Figueiredo AE, et al. ISPD catheter-related infection recommendations: 2017 update. Periton Dialys Intern. 2017;37(2):141-54.

Downloads

Published

2019-11-27

How to Cite

Intra, J., Sarto, C., Auricchio, S., Pozzi, M., Pieruzzi, F., & Brambilla, P. (2019). Fusarium solani infection after antimicrobial treatment of a severe bacterial peritonitis: a case report and review of the literature. International Journal of Research in Medical Sciences, 7(12), 4779–4782. https://doi.org/10.18203/2320-6012.ijrms20195556

Issue

Section

Case Reports